Alliancebernstein L.P. Aurinia Pharmaceuticals Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 135,500 shares of AUPH stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135,500
Previous 135,500
-0.0%
Holding current value
$1.53 Million
Previous $1.09 Million
5.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AUPH
# of Institutions
242Shares Held
62.3MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$114 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$105 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$44.9 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$31.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$27.1 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.61B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...